Mattel, Inc. MAT

Mattel, Inc. es una empresa de juguetes y propietaria de catálogos de franquicias de entretenimiento infantil y familiar en el mundo. Los segmentos de la compañía incluyen América del Norte, Internacional y American Girl. Su cartera de marcas y productos propios y con licencia se agrupan en cuatro categorías de marca: Muñecas, que incluye marcas como Barbie, Monster High, American Girl, Polly Pocket, Spirit (Universal) y Enchantimals; Bebés, Niños Pequeños y Preescolares incluye marcas como Fisher-Price y Thomas & Friends, Power Wheels y Fireman Sam; Vehículos incluye marcas como Hot Wheels, incluyendo Hot Wheels Monster Trucks y Hot Wheels Mario Kart (Nintendo), Matchbox y CARS (Disney Pixar), y Figuras de Acción, Sets de Construcción, Juegos y Otros incluyen marcas como Masters of the Universe, MEGA, UNO, Lightyear (Disney Pixar), Jurassic World (NBCUniversal), world wrestling entertainment (WWE) y Star Wars (Disney). Sus ofertas incluyen contenido de cine y televisión, juegos, música y eventos en vivo.

• Zacks Investment Research 1 oct

  Company News for Oct 1, 2026

  Recent economic data shows PCE inflation came in softer than expected while Q2 GDP exceeded expectations. Market attention is focused on the upcoming Friday employment report. Several companies reported earnings results with mixed stock performance: FactSet Research Systems beat earnings estimates and gained 3.8%, Concentrix outpaced estimates with a modest 0.3% gain, Hewlett Packard Enterprise surged 3.9% following a $1.2 billion deal with Vultr, while Mattel declined 4.2% after announcing a new CEO.

  

• The Motley Fool 3 sept

  A Mattel Executive Dumps Nearly 40,000 Shares After an 18% One-Year Decline in the Stock

  Mattel's Chief Supply Chain Officer Roberto Jacobo Isaias Zanatta sold 39,083 shares (21% of his direct equity stake) on August 31, 2026, at $15.02 per share, totaling approximately $587,000. The sale occurs amid an 18% one-year stock decline and disappointing company performance, including missed holiday sales expectations, Q2 net losses, and reduced full-year earnings guidance. The failed Masters of the Universe movie and unlikely Barbie sequel further weigh on the company's outlook.

  

• Zacks Investment Research 3 sept

  Why Is Mattel (MAT) Up 1.2% Since Last Earnings Report?

  Mattel reported Q2 2026 earnings of 1 cent per share, missing estimates by 66.7% due to higher advertising and administrative expenses, though net sales of $1.13 billion beat consensus. Growth was driven by Vehicles (Hot Wheels) and Action Figures, while Dolls and Preschool categories declined. Gross margins contracted 260 basis points due to tariffs and inflation. The company reaffirmed its 2026 outlook for 3-6% constant-currency sales growth and $1.27-$1.39 EPS. Mattel holds a Zacks Rank #3 (Hold) with upward estimate revisions.

  

• GlobeNewswire Inc. 30 jun

  France Licensing Day Breaks Records, Moves to New Paris Location in Biggest Edition Yet

  France Licensing Day 2026 achieved record attendance with 550+ attendees and 55 exhibitors at its new Paris venue on June 30. The event facilitated 500+ meetings between major brands including Paramount, Netflix, Warner Bros. Discovery, and Mattel with French retailers and licensees. The 8th annual Licensing International France Awards recognized excellence across 17 categories, with winners including Mattel's Barbie collaboration and Netflix's LEGO One Piece line.

  

• GlobeNewswire Inc. 11 jun

  The Sheri and Les Biller Family Foundation to Distribute Brave Barbie and Brave Ken Dolls to Cancer Care Organizations Serving Children and Families across the Country

  The Sheri and Les Biller Family Foundation, celebrating its 25th anniversary, partnered with Mattel Global Philanthropy to distribute 25 Brave Barbie and Brave Ken dolls to eight cancer care organizations serving children and families. The initiative aims to normalize children's cancer journeys and promote whole-person supportive cancer care, which addresses emotional, physical, and logistical needs alongside clinical treatment.